Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice

Oncology Letters

Volumn 4, Issue 6, 2012, Pages 1259-1263

  Zhou, Cheng Hua ^a   Wan, Ya Ya ^a   Chu, Xiang Hua ^b   Song, Zheng ^a   Xing, Shu Hua ^a   Wu, Yu Qing ^a   Yin, Xiao Xing ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Inflammatory microenvironment; Lung adenocarcinoma; Nude mice; Urotensin II

Indexed keywords

CD68 ANTIGEN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UROTENSIN II; UROTENSIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

EID: 84867271944     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.932     Document Type: Article

References (35)

1. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
2. Gonda TA, Tu S and Wang TC: Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle 8: 2005-2013, 2009.
3. Marx J: Cancer research. Inflammation and cancer: the link grows stronger. Science 306: 966-968, 2004.
4. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
5. Kang JC, Chen JS, Lee CH, Chang JJ and Shieh YS: Intratumoral macrophage counts correlate with tumor progression in colorectal cancer. J Surg Oncol 102: 242-248, 2010.
6. Lin JY, Li XY, Tadashi N and Dong P: Clinical significance of tumor-associated macrophage infiltration in supraglottic laryngeal carcinoma. Chin J Cancer 30: 280-286, 2011.
7. Fujiwara T, Fukushi J, Yamamoto S, et al: Macrophage infiltration predicts a poor prognosis for human ewing sarcoma. Am J Pathol 179: 1157-1170, 2011.
8. Lu H, Ouyang W and Huang C: Inflammation, a key event in cancer development. Mol Cancer Res 4: 221-233, 2006.
9. Cho WC, Kwan CK, Yau S, So PP, Poon PC and Au JS: The role of inflammation in the pathogenesis of lung cancer. Expert Opin Ther Targets 15: 1127-1137, 2011.
10. O'Callaghan DS, O'Donnell D, O'Connell F and O'Byrne KJ: The role of inflammation in the pathogenesis of non-small cell lung cancer. J Thorac Oncol 5: 2024-2036, 2010.
11. Lee G, Walser TC and Dubinett SM: Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med 15: 303-307, 2009.
12. Walser T, Cui X, Yanagawa J, et al: Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc 5: 811-815, 2008.
13. Takahashi H, Ogata H, Nishigaki R, Broide DH and Karin M: Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 17: 89-97, 2010.
14. Slatore CG, Au DH, Littman AJ, Satia JA and White E: Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study. Cancer Epidemiol Biomarkers Prev 18: 1203-1207, 2009.
15. Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Koenig KL and Shore RE: Aspirin and lung cancer in women. Br J Cancer 87: 49-53, 2002.
16. Pearson D, Shively JE, Clark BR, et al: Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci USA 77: 5021-5024, 1980.
17. Coulouarn Y, Lihrmann I, Jegou S, et al: Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95: 15803-15808, 1998.
18. Elshourbagy NA, Douglas SA, Shabon U, et al: Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br J Pharmacol 136: 9-22, 2002.
19. Coulouarn Y, Jégou S, Tostivint H, Vaudry H and Lihrmann I: Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457: 28-32, 1999.
20. Ames RS, Sarau HM, Chambers JK, et al: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401: 282-286, 1999.
21. Davenport AP and Maguire JJ: Urotensin II: fish neuropeptide catches orphan receptor. Trends Pharmacol Sci 21: 80-82, 2000.
22. Johns DG, Ao Z, Naselsky D, et al: Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Naunyn Schmiedebergs Arch Pharmacol 370: 238-250, 2004.
23. Segain JP, Rolli-Derkinderen M, Gervois N, Raingeard de la Blétière D, Loirand G and Pacaud P: Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes. J Immunol 179: 901-909, 2007.
24. Cirillo P, De Rosa S, Pacileo M, et al: Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease. J Thromb Haemost 6: 726-736, 2008.
25. Bousette N, Patel L, Douglas SA, Ohlstein EH and Giaid A: Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. Atherosclerosis 176: 117-123, 2004.
26. Birker-Robaczewska M, Boukhadra C, Studer R, Mueller C, Binkert C and Nayler O: The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma. J Recept Signal Transduct Res 23: 289-305, 2003.
27. Wu YQ, Song Z, Zhou CH, Xing SH, Pei DS and Zheng JN: Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo. Oncol Rep 24: 1179-1184, 2010.
28. Shi J, Zheng D, Liu Y, Sham MH, Tam P, Farzaneh F and Xu R: Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice. Cancer Res 65: 1687-1692, 2005.
29. Kawahara A, Hattori S, Akiba J, et al: Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer. Oncol Rep 24: 405-415, 2010.
30. Kurahara H, Shinchi H, Mataki Y, et al: Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 167: e211-219, 2009.
31. Lee CH, Espinosa I, Vrijaldenhoven S, et al: Prognostic significance of macrophage infiltration in leiomyosarcomas. Clin Cancer Res 14: 1423-1430, 2008.
32. Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA and Fagin JA: Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 15: 1069-1074, 2008.
33. Sica A: Role of tumour-associated macrophages in cancer-related inflammation. Exp Oncol 32: 153-158, 2010.
34. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK and Sethi G: Inflammation and cancer: how hot is the link? Biochem Pharmacol 72: 1605-1621, 2006.
35. Sun J, Ramnath RD, Zhi L, Tamizhselvi R and Bhatia M: Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways. Am J Physiol Cell Physiol 294: C1586-1596, 2008.